We are 55x cheaper than any current solution in the market.
We only need a small drop of blood. Moreover, our test does not need specialized professional to be executed and it is portable. Therefore, it can be distributed through any channel.
We are focused on the 17 types of cancer which account for more than 90% of the cases. Cancer early diagnosis is now systematic and possible.
This technology empowers us to create a portable and convenient test.
It help us understand cancer from more points of view, leading to a better prediction, prevention, diagnosis and treatment.
Empowers us to build intelligent tests, which are able to learn independently. We will be able to offer more precise tests, adapted to the patient.
AIM is a startup aiming at changing the future of healthcare through distance-regular monitoring. By diagnosing different diseases at the right time, we are increasing the chances of winning by 300%.
.png)
